GEN Exclusives

More »

GEN News Highlights

More »
Aug 14, 2012

Horizon Strikes X-Man Deal with ATCC

  • Horizon Discovery granted biological resources provider American Type Culture Collection (ATCC) a license to distribute a select set of its X-Man™ isogenic cell lines to academic and nonprofit customers as a part or in conjuction with ATCC’s own Tumor Cell Panels, for noncommercial research applications. The agreement, wihich excludes Japan, also doesn’t cover distribution of the X-Man cell lines in isolation.

    “Horizon’s X-Man cell line panels are a great complement for ATCC Tumor Cell Panels and will be a valuable resource for our customers,” comments Raymond Cypess, Ph.D., ATCC CEO. “The ability to work with accurate disease model cell lines is of great benefit, particularly in oncology research where many mutations studied are rare, and reliable sources of patient-derived cell lines are scarce.” 


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Megamerger Dealzapoppin Poll

What company not in this week’s M&A headlines do you think will be at the center of a megamerger, acquisition, or partial selloff this year?